Winton Group LTD X Biotech Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$10.95 - $16.07 $231,307 - $339,462	-21,124 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$12.95 - $18.24 $32,387 - $45,618	2,501 Added 13.43%	21,124 $274,000
Q2 2021 Aug 10, 2021	BUY	$15.83 - $17.84 $35,617 - $40,140	2,250 Added 13.74%	18,623 $308,000
Q1 2021 Jul 21, 2021	BUY	$15.92 - $20.3 $50,211 - $64,026	3,154 Added 23.86%	16,373 $281,000
Q4 2020 Feb 12, 2021	SELL	$15.65 - $19.92 $337,993 - $430,212	-21,597 Reduced 62.03%	13,219 $207,000
Q3 2020 Oct 30, 2020	BUY	$13.97 - $21.16 $37,188 - $56,327	2,662 Added 8.28%	34,816 $665,000
Q2 2020 Aug 05, 2020	BUY	$10.39 - $16.07 $334,080 - $516,714	32,154 New	32,154 $441,000
Q4 2019 Feb 13, 2020	SELL	$8.33 - $19.95 $283,403 - $678,738	-34,022 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$6.86 - $10.46 $233,390 - $355,870	34,022 New	34,022 $356,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $135M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.